Medesis Pharma SA (ALMDP.PA) Stock Analyst Ratings
Europe - EPA:ALMDP - FR0010844464 - Common Stock
0.35 EUR
-0.03 (-8.14%)
ChartMill assigns a Buy % Consensus number of 40% to ALMDP.PA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 0.82. This target is 133.14% above the current price.
ALMDP.PA was analyzed by 7 analysts. The buy percentage consensus is at 40. So analysts seem to be rather negative about ALMDP.PA.
In the previous month the buy percentage consensus was at a similar level.
ALMDP.PA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
Medesis Pharma SA / ALMDP.PA FAQ
What do analysts expect the price target to be for Medesis Pharma SA (ALMDP.PA)?
7 analysts have analysed ALMDP.PA and the average price target is 0.82 EUR. This implies a price increase of 133.14% is expected in the next year compared to the current price of 0.35.
How do analysts rate Medesis Pharma SA (ALMDP.PA)?
The consensus rating for Medesis Pharma SA (ALMDP.PA) is 40 / 100 . This indicates that analysts generally have a neutral outlook on the stock.